Literature DB >> 11429398

The effects of flecainide on ATP-sensitive K(+) channels in pig urethral myocytes.

T Yunoki1, N Teramoto, S Naito, Y Ito.   

Abstract

The effects of the antiarrhythmic drug flecainide on levcromakalim-induced hyperpolarization, macroscopic and unitary K(+) currents in pig urethra were investigated using patch-clamp techniques. The effects of flecainide were also examined on currents in inside-out patches of COS7 cells expressing carboxy terminus truncated inwardly rectifying K(+) channel (Kir6.2) subunits (i.e. Kir6.2DeltaC36) which form ATP-sensitive K(+) channels (K(ATP) channels). In current-clamp mode, application of flecainide (> or =100 microM) caused a significant depolarization after the membrane potential had been hyperpolarized by levcromakalim. In voltage-clamp experiments, the levcromakalim-induced outward current was suppressed by 300 microM flecainide in quasi-physiological K(+) conditions (K(i)=51 microM). In contrast, approximately 20% of the levcromakalim-induced inward current still remained even after application of 300 microM flecainide in symmetrical 140 mM K(+) conditions (K(i)=51 microM). In contrast, approximately 20% of the levcromakalim-induced inwar=126 microM). In cell-attached configuration, the channel activity of the levcromakalim-induced K(ATP) channels was reversibly inhibited by flecainide (> or =30 microM) at -50 mV. Their activity was also suppressed by either disopyramide or cibenzoline. Flecainide reversibly inhibited the channel activity of Kir6.2DeltaC36 expressed in COS7 cells using inside-out configuration. Inhibitory effects of flecainide on the levcromakalim-induced currents became more potent when the value of external pH increased, although this slightly reduced the proportion of drug molecules carrying a positive charge. These results suggest that flecainide inhibits channel activity through blocking the pore site of the K(ATP) channel in pig urethra.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429398      PMCID: PMC1572826          DOI: 10.1038/sj.bjp.0704109

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Properties and pharmacological modification of ATP-sensitive K(+) channels in cat tracheal myocytes.

Authors:  N Teramoto; T Nakashima; Y Ito
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 2.  Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell line.

Authors:  T R Miller; R D Taber; E J Molinari; K L Whiteaker; L M Monteggia; V E Scott; J D Brioni; J P Sullivan; M Gopalakrishnan
Journal:  Eur J Pharmacol       Date:  1999-04-09       Impact factor: 4.432

Review 3.  Antiarrhythmic drugs.

Authors:  R L Woosley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1991       Impact factor: 13.820

4.  Comparative studies of ATP sensitive potassium channels in heart and pancreatic beta cells using Vaughan-Williams class Ia antiarrhythmics.

Authors:  M Horie; S Hayashi; Y Yuzuki; S Sasayama
Journal:  Cardiovasc Res       Date:  1992-11       Impact factor: 10.787

5.  Inhibition of ICa in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin.

Authors:  F Scamps; A Undrovinas; G Vassort
Journal:  Am J Physiol       Date:  1989-03

6.  Effects of intracellular pH on ATP-sensitive K+ channels in mouse pancreatic beta-cells.

Authors:  P Proks; M Takano; F M Ashcroft
Journal:  J Physiol       Date:  1994-02-15       Impact factor: 5.182

7.  Inhibition of the ATP-sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic beta-cells.

Authors:  M Kakei; M Nakazaki; T Kamisaki; I Nagayama; Y Fukamachi; H Tanaka
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Disopyramide-induced urinary retention. Report of nine cases and review of the literature.

Authors:  L H Danziger; J R Horn
Journal:  Arch Intern Med       Date:  1983-09

9.  K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.

Authors:  M T Slawsky; N A Castle
Journal:  J Pharmacol Exp Ther       Date:  1994-04       Impact factor: 4.030

Review 10.  Current concepts in the treatment of disorders of micturition.

Authors:  K E Andersson
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

View more
  1 in total

1.  Characterization of the A-type potassium current in murine gastric antrum.

Authors:  Gregory C Amberg; Salah A Baker; Sang Don Koh; William J Hatton; Keith J Murray; Burton Horowitz; Kenton M Sanders
Journal:  J Physiol       Date:  2002-10-15       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.